AU510252B2 - N-acetyl thienamycin type antibiotics - Google Patents
N-acetyl thienamycin type antibioticsInfo
- Publication number
- AU510252B2 AU510252B2 AU19645/76A AU1964576A AU510252B2 AU 510252 B2 AU510252 B2 AU 510252B2 AU 19645/76 A AU19645/76 A AU 19645/76A AU 1964576 A AU1964576 A AU 1964576A AU 510252 B2 AU510252 B2 AU 510252B2
- Authority
- AU
- Australia
- Prior art keywords
- type antibiotics
- acetyl thienamycin
- acetyl
- thienamycin type
- antibiotics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
- C12P17/184—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63456075A | 1975-11-24 | 1975-11-24 | |
USUS634,560 | 1975-11-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU1964576A AU1964576A (en) | 1978-05-25 |
AU510252B2 true AU510252B2 (en) | 1980-06-19 |
Family
ID=24544292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU19645/76A Expired AU510252B2 (en) | 1975-11-24 | 1976-11-15 | N-acetyl thienamycin type antibiotics |
Country Status (16)
Country | Link |
---|---|
JP (1) | JPS5265295A (en) |
AR (1) | AR224224A1 (en) |
AU (1) | AU510252B2 (en) |
BE (1) | BE848349A (en) |
CH (1) | CH625803A5 (en) |
DE (1) | DE2652678A1 (en) |
DK (1) | DK497476A (en) |
ES (1) | ES453508A1 (en) |
FR (1) | FR2351979A1 (en) |
GB (1) | GB1561108A (en) |
GR (1) | GR61407B (en) |
HU (1) | HU175266B (en) |
NL (1) | NL7612932A (en) |
PT (1) | PT65845B (en) |
SE (1) | SE7612295L (en) |
ZA (1) | ZA766986B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7800957A (en) * | 1977-02-11 | 1978-08-15 | Merck & Co Inc | ANTIBIOTIC DESACETYL 890 A10, METHOD FOR PREPARING THIS, AND PHARMACEUTICAL PREPARATIONS CONTAINING THIS ANTIBIOTIC. |
SE7800979L (en) * | 1977-02-11 | 1978-08-12 | Merck & Co Inc | ANTIBIOTIC |
US4162193A (en) * | 1977-08-19 | 1979-07-24 | Merck & Co., Inc. | Enzymatic cleavage of N-acyl-thienamycins |
NZ190994A (en) | 1978-07-24 | 1981-10-19 | Merck & Co Inc | Z-2-acylamino-3-monosubstituted propenoates |
EP0024447B1 (en) * | 1979-08-28 | 1983-07-20 | Merck & Co. Inc. | Process for purifying thienamycin |
DE3146190A1 (en) * | 1981-11-21 | 1983-06-16 | Hoechst Ag, 6230 Frankfurt | INSULATION OF CHEMICALLY UNSTABLE ANTIBIOTICS FROM FERMENTATION SOLUTIONS |
US10695322B2 (en) | 2016-01-29 | 2020-06-30 | The Johns Hopkins University | Inhibitors of bacterial growth |
-
1976
- 1976-11-03 DK DK497476A patent/DK497476A/en not_active Application Discontinuation
- 1976-11-04 SE SE7612295A patent/SE7612295L/en not_active Application Discontinuation
- 1976-11-15 AU AU19645/76A patent/AU510252B2/en not_active Expired
- 1976-11-16 AR AR265526A patent/AR224224A1/en active
- 1976-11-16 BE BE172363A patent/BE848349A/en not_active IP Right Cessation
- 1976-11-16 PT PT65845A patent/PT65845B/en unknown
- 1976-11-18 HU HUME002031 patent/HU175266B/en unknown
- 1976-11-19 FR FR7634889A patent/FR2351979A1/en active Granted
- 1976-11-19 CH CH1459976A patent/CH625803A5/en not_active IP Right Cessation
- 1976-11-19 ES ES453508A patent/ES453508A1/en not_active Expired
- 1976-11-19 GB GB48233/76A patent/GB1561108A/en not_active Expired
- 1976-11-19 NL NL7612932A patent/NL7612932A/en not_active Application Discontinuation
- 1976-11-19 DE DE19762652678 patent/DE2652678A1/en not_active Withdrawn
- 1976-11-20 GR GR52224A patent/GR61407B/en unknown
- 1976-11-22 JP JP51139656A patent/JPS5265295A/en active Pending
- 1976-11-23 ZA ZA00766986A patent/ZA766986B/en unknown
Also Published As
Publication number | Publication date |
---|---|
GR61407B (en) | 1978-11-11 |
DE2652678A1 (en) | 1977-06-02 |
BE848349A (en) | 1977-05-16 |
JPS5265295A (en) | 1977-05-30 |
GB1561108A (en) | 1980-02-13 |
PT65845B (en) | 1978-10-10 |
FR2351979B1 (en) | 1982-08-13 |
SE7612295L (en) | 1977-05-25 |
HU175266B (en) | 1980-06-28 |
ES453508A1 (en) | 1978-03-01 |
FR2351979A1 (en) | 1977-12-16 |
CH625803A5 (en) | 1981-10-15 |
ZA766986B (en) | 1978-06-28 |
NL7612932A (en) | 1977-05-26 |
DK497476A (en) | 1977-05-25 |
AR224224A1 (en) | 1981-11-13 |
AU1964576A (en) | 1978-05-25 |
PT65845A (en) | 1976-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU501202B2 (en) | New antibiotic substances | |
AU508764B2 (en) | Glucosamine derivatives | |
AU502662B2 (en) | N-substituted halo-2-pyrrolidinones | |
AU502846B2 (en) | Sreptomycetal antibiotic | |
AU497365B2 (en) | Antibiotic | |
AU510252B2 (en) | N-acetyl thienamycin type antibiotics | |
AU499566B2 (en) | Rosamycia (antibiotic 67-694) derivatives | |
AU508264B2 (en) | Penicillins | |
AU501362B2 (en) | Cephalosporins | |
AU500339B2 (en) | Penicillins | |
AU1382976A (en) | Cephalosporins | |
AU1082476A (en) | Cephalosporins | |
AU497576B2 (en) | Antibiotic | |
AU507317B2 (en) | Antibiotic form micromonspra olivoasterpora | |
AU506777B2 (en) | Antibiotics from aspergillys rugulosys | |
AU498095B2 (en) | Antibiotics | |
AU514309B2 (en) | N-acetyl thienmycin | |
AU503105B2 (en) | Aminocyclitol antibiotics | |
AU503269B2 (en) | Antibiotic xk-62-2 derivatives | |
AU507922B2 (en) | Antibiotic A-22b02 | |
AU1910176A (en) | Cephalosporins | |
AU493309B2 (en) | Antibiotics | |
AU498022B2 (en) | B-lactam compounds | |
AU5049679A (en) | Azetidinone derivatives | |
AU490577B2 (en) | Antibiotic compounds |